Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
British Journal of Clinical Pharmacology|April 23, 2017
Tenapanor administration and the activity of the H+ -coupled transporter PepT1 in healthy volunteersSusanne Johansson, David P Rosenbaum, Johan Palm, et al.Journal of Medicinal Chemistry|December 10, 2025
Conformational Dynamics in the Cell Membrane Interactions of Bispecific Targeted Degrader TherapeuticsEmma Inganäs, Hanna Lavén, Rémi Caraballo, et al.The Journal of Pharmacology and Experimental Therapeutics|June 2, 2021
In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug TransportersV Sashi Gopaul, Anna Vildhede, Tommy B Andersson, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 15, 2010
High-activity p-glycoprotein, multidrug resistance protein 2, and breast cancer resistance protein membrane vesicles prepared from transiently transfected human embryonic kidney 293-epstein-barr virus nuclear antigen cellsJohan E Karlsson, Catherine Heddle, Aleksei Rozkov, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 28, 2011
Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport functionTasso Miliotis, Liaqat Ali, Johan E Palm, et al.Pharmacology Research & Perspectives|April 16, 2025
In Vitro Structure-Activity Relationship Stability Study of Antisense Oligonucleotide Therapeutics Using Biological Matrices and NucleasesJelena Lovrić, Jingjing Yan, XueQing Li, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 2, 2012
Characterization of THLE-cytochrome P450 (P450) cell lines: gene expression background and relationship to P450-enzyme activityYalda Soltanpour, Constanze Hilgendorf, Marie M Ahlström, et al.The AAPS Journal|March 12, 2016
Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass EliminationChristopher R Jones, Oliver J D Hatley, Anna-Lena Ungell, et al.Pharmaceutics|December 24, 2015
Montelukast Disposition: No Indication of Transporter-Mediated Uptake in OATP2B1 and OATP1B1 Expressing HEK293 CellsMarie Brännström, Pär Nordell, Britta Bonn, et al.Scientific Reports|July 27, 2017
Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axisAnna Nilsson, Alexandra Peric, Marie Strimfors, et al.Pageof 4